C12orf12 inhibitors are a class of chemical compounds specifically designed to target and regulate the activity of the C12orf12 protein, an enigmatic protein encoded by the C12orf12 gene. While the precise biological function of C12orf12 is not yet fully elucidated, it is believed to be involved in various cellular processes, potentially including aspects of cellular signaling, structural organization, or metabolic regulation. The development of inhibitors for C12orf12 is primarily driven by the need to explore and understand the role of this protein in these fundamental cellular activities. By inhibiting C12orf12, researchers can observe the effects of its loss of function, thereby gaining insights into the pathways and processes it may influence.
The development process for C12orf12 inhibitors involves several key steps, beginning with the structural characterization of the C12orf12 protein. Techniques such as X-ray crystallography and cryo-electron microscopy are utilized to determine the three-dimensional structure of C12orf12, focusing on identifying potential active sites, binding pockets, or domains critical for its function. This structural information is crucial for the rational design of inhibitors that can effectively bind to these sites, disrupting the protein's normal activity. Computational modeling and molecular docking studies are often employed to screen for chemical compounds that can interact with C12orf12 with high specificity and affinity. Once potential inhibitors are identified, they are synthesized and tested in biochemical assays to evaluate their binding properties, inhibitory potency, and effects on the protein's activity. Through iterative cycles of design, synthesis, and testing, these inhibitors are optimized to enhance their effectiveness and selectivity. The study of C12orf12 inhibitors not only advances the understanding of the specific functions of this protein but also provides valuable tools for dissecting the molecular mechanisms underlying the cellular processes in which C12orf12 may be involved.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $113.00 $423.00 | ||
This chemical is a checkpoint kinase inhibitor that can inhibit C12orf12 by disrupting the cell cycle checkpoints with which C12orf12 is associated, thereby impairing the protein's function in cell cycle regulation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Inhibits cyclin-dependent kinases (CDKs) which are essential for the cell cycle progression, potentially impeding the function of C12orf12 if it is involved in cell cycle processes regulated by CDKs. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Selectively inhibits CDK4/6, and if C12orf12 plays a role in Rb phosphorylation and G1-S phase transition, this would result in functional inhibition of C12orf12. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Inhibits PARP enzymes and could inhibit C12orf12 by preventing the repair of DNA damage, possibly reducing the protein's function related to DNA damage response. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
Inhibits ATR kinase and could affect C12orf12 by inhibiting ATR-dependent signaling pathways, potentially impacting protein's role in response to DNA damage or replication stress. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
This is a DNA-PKcs inhibitor that could inhibit C12orf12 by disrupting the DNA damage response, particularly non-homologous end joining (NHEJ), assuming C12orf12 has a role in this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K and could inhibit C12orf12 by disrupting PI3K-related signaling pathways which may be involved in the regulation or function of C12orf12. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that may inhibit C12orf12 by blocking PI3K/Akt signaling, which could be implicated in processes involving C12orf12, such as cell proliferation or survival. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK inhibitor that could inhibit C12orf12 by blocking the MAPK/ERK pathway, potentially affecting the protein's function if it is involved in pathways related to cell growth and differentiation driven by MAPK/ERK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor that could inhibit C12orf12 by blocking the JNK signaling pathway, which may be necessary for the function of C12orf12 if it is involved in stress or inflammatory response pathways. |